NIA set to build $300M ‘real world’ Alzheimer’s database
By
Alicia Lasek
Apr 06, 2023
The goal is to collect real-world data on Alzheimer’s disease and create a centralized data hub, helping to expand and speed Alzheimer’s research.
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
NIH panel updates treatment guidelines for non-hospitalized COVID-19 patients
By
Alicia Lasek
Jan 25, 2022
A new recommended treatments list addresses the omicron variant’s current dominance and drug supply shortages.
Antigen tests just as effective as PCR in preventing COVID outbreaks, NIH study finds
By
Alicia Lasek
Jul 02, 2021
A “highly anticipated” study now shows that both testing approaches can give 98% sensitivity when used at least twice weekly in a screening program.
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.